May 27, 2015
In the last two months, the FDA has cleared a number of clinically-focused mobile health devices. Some are first-time clearances for companies that have been waiting on their 510(k) for a while, including a few MobiHealthNews has been keeping an eye on over the years. Others are incremental clearances for slight hardware or algorithm updates. Here's five mobile health clearances that came through...
April 21, 2015
Sotera Wireless's ViSi Mobile monitor.
Last year Taiwan-based electronics manufacturer Foxconn quietly acquired a stake in continuous vital signs monitoring company Sotera Wireless for an undisclosed sum. (As MobiHealthNews reported at the time, an SEC filing last April showed that Sotera had raised $20 million from undisclosed backers.) The Wall Street Journal recently reported that Foxconn...
December 18, 2013
Scripps Health is piloting Sotera Wireless's ViSi mobile, a wireless patient monitoring system, with up to 30 patients at Scripps Green Hospital in La Jolla, California. Although the Scripps Translational Science Institute has investigated ViSi devices before, this pilot marks the first time Scripps has used the device in a real-world clinical setting.
The ViSi Mobile system continuously monitors...
November 14, 2013
Dr. Eric Topol, one of the most well known figures in digital health and Dr. Deepak Chopra, one of the most prominent voices in alternative medicine, are teaming up to measure the effects of meditation with digital health devices. The study of 40 individuals was conducted by the Scripps Translational Science Institute with funding from the Chopra Foundation.
"Although the health benefits of...
May 20, 2013
Sotera Wireless, the San Diego-based in-hospital mobile wireless monitoring company that's raised nearly $60 million from investors like Qualcomm and Intel, announced a deal with Utah-based healthcare system Intermountain Healthcare.
Back in March at HIMSS, Sotera announced it was piloting its ViSi Mobile wireless patient monitoring platform with two Intermountain hospitals, its flagship...
February 7, 2013
Sotera Wireless, maker of the wrist-worn ViSi Mobile wireless vitals monitoring system, has landed $14.8 million in fresh capital, including $1.33 million from Safeguard Scientifics and an undisclosed amount from another new investor, Delphi Ventures.
Other participants in this round include previous shareholders Sanderling Ventures, Qualcomm Ventures, EDBI, Intel Capital, Cerner Capital and the...
February 16, 2012
Denmark-based medical device company Sense A/S just announced a €4.5 million ($5.9 million) round of funding from venture fund SEED Capital and Vaekstfonden to help it refine its cuffless blood pressure measurement device. The company expects to secure FDA 510(K) clearance for the device and have it launch commercially next year. (Last year SEED invested $2.3 million in another Danish startup,...
July 13, 2011
Design concept for ViSi Mobile - Not Yet FDA Cleared
Sotera Wireless has secured a new round $7 million in financing that includes a mix of debt and other securities. Some of Sotera Wireless’ previous investors have included West Family Holdings, Qualcomm Ventures, Intel Capital, Sanderling Ventures and Apposite Capital. Last April the company raised $10.75 million. Including the most recent $7...
April 14, 2010
According to a regulatory filing with the SEC this week, Sotera Wireless has secured $10.75 million of a $15 million round of venture funding from undisclosed investor(s). Some of Sotera Wireless' previous investors have included Qualcomm Ventures, Intel Capital, Sanderling Ventures and Apposite Capital.
Sotera Wireless, which changed its name from Triage Wireless last year, is currently...
November 16, 2009
San Diego, California-based start-up Triage Wireless has changed its name to Sotera Wireless as part of an agreement with Inverness Medical Innovations, which markets products under the Triage brand.
Triage Wireless, now Sotera Wireless, has close ties to Qualcomm and is developing continuous, non-invasive blood pressure monitoring technology with arterial-line accuracy and without the need for...